Parthenolide inhibits hydrogen peroxide‑induced osteoblast apoptosis

  • Authors:
    • Weihuan Mao
    • Ziguan Zhu
  • View Affiliations

  • Published online on: April 20, 2018     https://doi.org/10.3892/mmr.2018.8908
  • Pages: 8369-8376
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Parthenolide is a natural product from the shoots of Tanacetum parthenium that has been demonstrated to have immunomodulatory effects in a number of diseases. The present study aimed to determine the effect and mechanism of parthenolide on the apoptotic ability of H2O2‑induced osteoblasts. Cell viability was analyzed with a MTT assay and the apoptotic rate was subsequently measured using flow cytometry. The activity of the antioxidative enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPX), and the serum marker enzymes alkaline phosphatase (ALP), malondialdehyde (MDA) and lactate dehydrogenase (LDH) was measured. Reverse transcription‑quantitative polymerase chain reaction and western blot analyses were performed to analyze the expression levels of osteogenesis and oxidative stress‑associated genes. The results indicated that parthenolide increased cell viability and inhibited the apoptosis of H2O2‑induced osteoblasts. Parthenolide decreased the levels of reactive oxygen species, MDA, LDH and ALP. SOD and GPX levels were increased by parthenolide in H2O2‑induced osteoblasts. This suggested that parthenolide may break the equilibrium state of oxidative stress and inhibit cellular apoptosis. Parthenolide additionally increased the expression levels of oxidative stress‑associated genes, including nuclear factor erythroid 2 like 2, hemeoxygenase‑1 and quinone oxidoreductase 1 in H2O2‑induced osteoblasts. Furthermore, parthenolide increased the expression of osteogenesis‑associated genes, including runt‑related transcription factor 2, osteopontin, osteocalcin and collagen 1 in H2O2‑inducedosteoblasts. Therefore, it was concluded that parthenolide may be used in the treatment of osteoporosis.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 17 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Mao W and Mao W: Parthenolide inhibits hydrogen peroxide‑induced osteoblast apoptosis. Mol Med Rep 17: 8369-8376, 2018
APA
Mao, W., & Mao, W. (2018). Parthenolide inhibits hydrogen peroxide‑induced osteoblast apoptosis. Molecular Medicine Reports, 17, 8369-8376. https://doi.org/10.3892/mmr.2018.8908
MLA
Mao, W., Zhu, Z."Parthenolide inhibits hydrogen peroxide‑induced osteoblast apoptosis". Molecular Medicine Reports 17.6 (2018): 8369-8376.
Chicago
Mao, W., Zhu, Z."Parthenolide inhibits hydrogen peroxide‑induced osteoblast apoptosis". Molecular Medicine Reports 17, no. 6 (2018): 8369-8376. https://doi.org/10.3892/mmr.2018.8908